Biotech Across America Roadshow Launches: North Carolina Emerges as the Epicenter of U.S. Bio-Innovation and Growth
NSCEB’s biotech roadshow kicks off in North Carolina, spotlighting biomanufacturing, workforce growth, and game-changing U.S. innovations for 2025.
- $2.9T global biotech market projected by 2025
- 90,000+ jobs supported by North Carolina’s biotech sector
- 48 states to be visited during the NSCEB roadshow
- 40+ years of NC investment in biotechnology
America’s biotechnology industry is having a breakout year—and the movement started in North Carolina. Michelle Rozo, Vice Chair of the National Science and Technology Council’s Biotechnology Education and Outreach Board (NSCEB), just ignited the Biotech Across America roadshow, a coast-to-coast celebration aiming to reveal what—and who—is truly powering the next wave of U.S. innovation, economic security, and job creation.
The journey kicked off in Raleigh, where biotech leaders, policy-makers, and innovators came together to discuss the future of life sciences. With the U.S. racing to shore up supply chains and capitalize on cutting-edge discoveries, the spotlight is now on states like North Carolina, already proving they mean serious business in biomanufacturing, pharmaceutical advances, agricultural technology, and workforce development.
What Sparked the National Biotech Roadshow in 2025?
The NSCEB’s new push marks a pivotal chapter for biotechnology in the U.S. The Biotech Across America initiative aims to bridge the gap between policy and practice, taking Congress’s most recent recommendations straight to the people and companies shaping biotech’s future on the ground.
At kickoff, Dr. Rozo emphasized the urgent need to hear directly from those in the trenches, collaborating to strengthen the national biotech ecosystem and protect economic and national security. This approach marks a shift toward unprecedented transparency and community engagement—one that industry observers say is essential as the market hurtles toward a projected $2.9 trillion globally by year-end.
How Is North Carolina Leading the National Biotech Surge?
North Carolina didn’t just host the starting line; the state is now a blueprint for the country’s bio-based ambitions. Leaders from the North Carolina Biotechnology Center (NCBiotech), state legislators, and executives from North Carolina Life Sciences Caucus showcased the formidable alliances driving success in research, regulatory support, and global exports.
They revealed North Carolina’s secret to biotech dominance: robust legislation, partnerships between academia and the private sector, and a talent pipeline that rivals the world’s technology capitals. The success of job training programs, emphasis on local biomanufacturing, and readiness to onshore critical supply chains set the state apart—and offer a roadmap for others.
During the Raleigh roundtable, stakeholders outlined how expanded manufacturing capacity is not just creating jobs but also safeguarding U.S. supply chains—a hot-button issue as policy shifts prioritize economic resilience.
What Are the Biggest Innovations Powering North Carolina’s Biotech Boom?
NSCEB commissioners witnessed local biotech breakthroughs firsthand at Novonesis’ enzyme manufacturing facility in Franklinton. Recent advancements in agricultural biotechnology are addressing food security, economic independence, and sustainability head-on.
Cutting-edge projects highlighted include:
– Enzyme technologies boosting crop yields and sustainability
– Bio-manufacturing platforms reducing environmental impact
– Workforce training that fast-tracks new graduates directly into high-demand biotech jobs
These innovations don’t just promise long-term growth—they’re already transforming community economies and setting new national standards.
Q&A: What’s Ahead for U.S. Biotechnology?
Q: Where does the roadshow go next?
Ambitiously, the NSCEB team will visit 48 states throughout 2025, to build partnerships, share breakthroughs, and lay the groundwork for national acceleration.
Q: How can other states replicate North Carolina’s biotech success?
By investing in workforce development, forging academia-industry alliances, promoting policy support, and prioritizing sustainability from lab-bench to manufacturing floor.
Q: Why does biotech matter for U.S. security and the economy?
Biotechnology is critical for securing supply chains, developing life-saving therapies, strengthening food security, and creating millions of high-quality jobs—all of which help solidify the U.S. as a global innovation leader.
Explore more U.S. science and biotech news at NIH, White House, and FDA.
How Can You Support the Biotech Revolution?
– If you’re a policy-maker: Foster cross-sector partnerships and invest in local training.
– If you’re an entrepreneur: Embrace innovative solutions and push for domestic scalability.
– If you’re a student or worker: Upskill with biotech and life sciences training programs, particularly in biomanufacturing and research.
Now is the time to act—learn, connect, and advocate for biotechnology in your state!
Biotech Action Checklist
- Support initiatives advancing U.S. biotech leadership
- Promote STEM education and local workforce training
- Champion legislation for advanced biomanufacturing
- Follow the NSCEB roadshow to stay inspired and informed
